Get the Stockscreener App
2.4901
4.01%
-0.1039
Bionexus Gene Lab Corp stock is traded at $2.4901, with a volume of 1,703.
It is down -4.01% in the last 24 hours and down -1.38% over the past month.
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
See More
Previous Close:
$2.594
Open:
$2.46
24h Volume:
1,703
Relative Volume:
0.10
Market Cap:
$5.89M
Revenue:
$9.47M
Net Income/Loss:
$-2.30M
P/E Ratio:
-1.9478
EPS:
-1.2784
Net Cash Flow:
$-2.87M
1W Performance:
-0.96%
1M Performance:
-1.38%
6M Performance:
-58.50%
1Y Performance:
-12.23%
1-Day Range:
$2.46
$2.55
1-Week Range:
$2.435
$2.68
52-Week Range:
$1.92
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Name
Bionexus Gene Lab Corp
Sector
Industry
Phone
1-307-241-6898
Address
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC vs PSNYW, SHMD, GOODO, DWLD, QQQE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
5.30 | 493.05M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
7.42 | 364.76M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
19.92 | 372.90M | 0 | 0 | 0 | 0.00 |
DWLD
Davis Select Worldwide ETF
|
43.93 | 0 | 0 | 0 | 0 | 0.00 |
QQQE
Direxion NASDAQ-100 Equal Weigh
|
99.50 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Stock (BGLC) Latest News
Will BioNexus Gene Lab Corp stock recover after earningsMarket Activity Recap & Safe Entry Trade Signal Reports - baoquankhu1.vn
Aug Highlights: Does LTRY have declining or rising EPS2026 Intraday Action & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Tech Rally: Will BioNexus Gene Lab Corp outperform its industry peersPortfolio Profit Report & Free Reliable Trade Execution Plans - baoquankhu1.vn
12 Industrials Stocks Moving In Wednesday's Pre-Market Session - Benzinga
BioNexus Gene Lab (NASDAQ: BGLC) taps new CCO to drive Fidelion VitaGuard MRD commercialization - Stock Titan
BioNexus Gene Lab appoints commercial officer at Fidelion By Investing.com - Investing.com Nigeria
BioNexus Gene Lab appoints commercial officer at Fidelion - Investing.com India
BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard MRD Platform - Bitget
BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform - The Manila Times
BioNexus Gene Lab Corp. Appoints Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics - Quiver Quantitative
Cancer relapse blood tests: Fidelion hires 15-year oncology diagnostics veteran - Stock Titan
12 Industrials Stocks Moving In Monday's Intraday Session - Sahm
Sell Signal: Is BioNexus Gene Lab Corp a strong candidate for buy and holdQuarterly Portfolio Review & Risk Managed Trade Strategies - baoquankhu1.vn
Breakouts Watch: Will BioNexus Gene Lab Corp stock recover after earningsJuly 2025 Levels & Growth Focused Stock Reports - baoquankhu1.vn
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman - Bitget
Chemrex board cut to two as BioNexus weighs new growth options - Stock Titan
BGLCBionexus Gene La Latest Stock News & Market Updates - Stock Titan
Financial Comparison: Beauty Health (NASDAQ:SKIN) vs. BioNexus Gene Lab (NASDAQ:BGLC) - Defense World
BioNexus Gene Lab (NASDAQ:BGLC) Stock Price Up 1.7% – Still a Buy? - Defense World
Sentiment Review: Does T Stamp Inc stock reflect fundamentalsJuly 2025 Sentiment & Smart Allocation Stock Tips - baoquankhu1.vn
Will BioNexus Gene Lab Corp. stock recover after earningsInsider Selling & Smart Swing Trading Alerts - mfd.ru
BGLC Should I Buy - Intellectia AI
Analyst Upgrade: What is the Moat Score of BioNexus Gene Lab CorpJuly 2025 Rallies & Weekly Market Pulse Alerts - baoquankhu1.vn
BioNexus Launches Regional Deployment of VitaGuard MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN's Multi-Billion Dollar Market - Finviz
BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market - marketscreener.com
BioNexus Launches Regional Deployment of VitaGuard™ MRD - GlobeNewswire
Analyst Calls: Is BioNexus Gene Lab Corp a strong candidate for buy and hold2025 Price Targets & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Block Trades: Will BioNexus Gene Lab Corp outperform its industry peersJuly 2025 Outlook & Fast Entry Momentum Alerts - baoquankhu1.vn
BioNexus Gene Lab stockholders back governance and incentive plan - MSN
Whale Trades: Can BioNexus Gene Lab Corp be the next market leaderMarket Performance Summary & Entry Point Confirmation Signals - baoquankhu1.vn
BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update - Defense World
Bearish Setup: Will BioNexus Gene Lab Corp outperform its industry peersJuly 2025 Summary & Consistent Return Investment Signals - baoquankhu1.vn
New Highs: Will QCR Holdings Inc stock recover after earningsDay Trade & Smart Swing Trading Alerts - baoquankhu1.vn
Why BioNexus Gene Lab Corp. stock is trending among retail tradersJuly 2025 Rallies & Precise Buy Zone Identification - Улправда
Insider Trends: Can BioNexus Gene Lab Corp. stock deliver sustainable ROEJuly 2025 Levels & Community Driven Trade Alerts - Улправда
How BioNexus Gene Lab Corp. stock reacts to job market dataJuly 2025 Intraday Action & Verified Stock Trade Ideas - Улправда
Can BioNexus Gene Lab Corp. stock deliver sustainable ROEJuly 2025 Levels & Community Driven Trade Alerts - ulpravda.ru
Why BioNexus Gene Lab Corp. stock is recommended by analystsJuly 2025 Chart Watch & AI Powered Market Entry Ideas - Улправда
Downgrade Watch: Can BioNexus Gene Lab Corp stock resist market sell offsShort Setup & Technical Pattern Alert System - moha.gov.vn
BioNexus Gene Lab Stockholders Back Governance and Incentive Plan - The Globe and Mail
BioNexus Gene Lab shareholders approve board, equity plan, and auditor at annual meeting - Investing.com Australia
BioNexus Gene Lab shareholders approve board, equity plan, and auditor at annual meeting By Investing.com - Investing.com South Africa
How supply chain issues affect BioNexus Gene Lab Corp. stockMarket Insider Reports & Capitalize On Fast Trends - bollywoodhelpline.com
BioNexus Gene Lab (NASDAQ:BGLC) Shares Down 0.2% – Should You Sell? - Defense World
BioNexus Gene Lab Shares Surge on Strategic MRD Testing Partnership - MSN
Bionexus Gene Lab Corp Stock (BGLC) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):